General Information


DRAVP ID  DRAVPe00413

Peptide Name   HR2(1151-1185)

Sequence  ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL

Sequence Length  35

UniProt ID  P59594 

Source  Synthetic construct(derived from SARS-CoV spike protein)



Activity Information


Target Organism  HIV

Assay 

Activity 

  • [Ref.18442051]HIV‐luc/SARS Pseudotyped Virus:inhibition of viral-entry in Vero E3 cells(EC50=0.34 µM).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity  No cytotoxicity information found in the reference(s) presented

Binding Target  Not found

Mechanism  No machanism information found in the reference(s) presented in this entry



Structure Information


PDB ID  None

Predicted Structure Download  No predicted structure available

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C168H287N47O58

Absent amino acids  CFHMPTWY

Common amino acids  ILN

Mass  3893.41

Pl  4.36

Basic residues  3

Acidic residues  6

Hydrophobic residues  15

Net charge  -3

Boman Index  -5930

Hydrophobicity  -8.29

Aliphatic Index  142

Half Life 

  •     Mammalian:20 hour
  •     Yeast:30 min
  •     E.coli:>10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  9



Literature Information


Literature 1

Title   Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors. 

Pubmed ID   18442051

Reference   J Cell Biochem. 2008 Aug 15;104(6):2335-47.

Author   Chu LH, Chan SH, Tsai SN, Wang Y, Cheng CH, Wong KB, Waye MM, Ngai SM.

DOI   10.1002/jcb.21790